Delivery Order SPE2DB20D9329-SPE2DB23FZJ87
Award Date 2/7/23
Potential Completion Date 2/8/23
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Ketorolac 30 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,252.32 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA...
- This federal contract award is for the delivery of Ketorolac Trometham, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,044.10 and a performance period ending on March 6, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,044.10 firm-fixed-price delivery order is for the supply of Ketorolac Trometham, a pharmaceutical product. The contract has a performance period through March 13, 2025. It is not a set-aside contract. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a $260.52 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4562275326 Ketorolac 60 mg/2 ml vials. The single-day order is for 2 ml vials of the nonsteroidal anti-inflammatory drug ketorolac and will be fulfilled from DMS's facility in Park Ridge, Illinois. No additional details were provided about the original solicitation or whether this delivery order was placed against an existing DLA contract vehicle. The DLA manages the global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,044.10 firm fixed-price delivery order is for the supply of Ketorolac Trometham, a medication used to manage moderate to severe pain. The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, with a ceiling value of $9,324.56 and a completion date of July 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999,...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Ketorolac Tromethamine, a pharmaceutical product, with a potential value of $3,085.91. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, a single-award vehicle valued up to $4,999,999 through 2025 that enables the agency to...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,041.60 to DMS Pharmaceutical Group Inc. for the supply of Ketorolac Tromethamine, a nonsteroidal anti-inflammatory medication commonly used for pain management in military healthcare settings. This firm fixed-price delivery order, issued on June 27, 2025, with an ultimate completion date of July 7, 2025, represents a discrete purchase order under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $5,088 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ketorolac 30 mg/ml vials. The award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $7,395.36 firm fixed-price delivery order placed under the Defense Logistics Agency's (DLA) SPE2DB program. The order is for the supply of 4561901111 - KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of August 23, 2023 and does not utilize any set-aside designations. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products...